Enovis falls after 2025 profit forecast cut

Shares of medical device maker Enovis Corp ENOV.N fall 8% to $31.51 premarket

ENOV cuts its annual profit forecast in the range of $2.95 to $3.10 per share, compared with previous projected range of $3.10 to $3.25

Co, however, raises its 2025 revenue forecast to be in the range of $2.22 billion to $2.25 billion, compared with prior view of $2.19 billion to $2.22 billion

"ENOV shares are underperforming on tariff fears," says Brokerage Evercore ISI

Reports Q1 adjusted profit of 81 cents per share vs estimates of 74 cents - data compiled by LSEG

Up to last close, stock had fallen ~22% YTD